Skip to main content
Rwanda FDA approves Purpose Life Sciences and GreenLight Biosciences to launch a Phase I clinical trial in Rwanda for mRNA COVID-19 vaccine
News

Rwanda FDA approves Purpose Life Sciences and GreenLight Biosciences to launch a Phase I clinical trial in Rwanda for mRNA COVID-19 vaccine

Purpose Life Sciences, a high impact Clinical Research Organization, with the mission to modernize clinical trials on a global scale, has signed a key agreement with GreenLight Biosciences to support their Phase I clinical trial, GLB-003, for a novel mRNA vaccine against COVID-19 in Rwanda – that today has been…
Purpose Life Sciences
February 2, 2023
Estimating HIV Incidence In Sub-Saharan Africa
Publications

Estimating HIV Incidence In Sub-Saharan Africa

Over the past 3 years, the COVID-19 pandemic has affected health systems in sub-Saharan Africa that were already highly burdened by other infectious diseases such as HIV. Although substantial progress has been made in reducing new HIV infections globally, Africa is still disproportionately affected, accounting for two-thirds of all people…
Purpose Life Sciences
January 23, 2023